.
We could all use some GOOD news about this, right?
GOOD NEWS BIT #1:
Well, here's a positive thing I failed to mention earlier. You know that French study where hydroxychloriquine and azithromycin together cured 100% of people after 5-6 days?
I mentioned it was hastily done and had many inadequacies (only 6 people got the two-drug combo and were cured, it was non-randomized and non-blinded, etc.)
Those are fairly dim clouds cast over the study, however, if you look at the statistical analysis, things get much brighter. "Significance" is generally agreed to begin when a result is 20-to-1 against chance (meaning there's only a 1 out of 20 probability that it happened randomly and the effect indicated is not real).
This study is 10,000-to-1 against chance. This means the probability of the study's findings being wrong (which would mean that two-drug combo is not effective) is THE SAME as the probability of you walking into a store and buying just a single "Pick 4" lottery ticket (the kind with four digits each from 0-9) and matching the drawn number perfectly.
GOOD NEWS BIT #2:
Remember I mentioned Africa having a very low infection rate, possibly because they use chloroquine / hydroxychloriquine widely for prevention and treatment of malaria?
Turns out it isn't just Africa. Southeast Asia and South America also use the drug widely for the same reason.
Guess who also has almost no COVID-19 cases? Yeah, Southeast Asia and South America. It's not just one data point (Africa) now, it's three, which is a considerably stronger confidence level.
Hence my optimism about the two-drug combo. About 4-5 more days and I suspect we'll be hearing the "wow!" reports coming in from the field, even though the large-scale, tightly-controlled, formalized study's results will be months away. But if so, nobody will care much about the formal study, it'll be "off to the races" with mass deployment for curing and possibly prevention too (given to healthcare workers first, likely, as they're at highest risk).
.
Pudding Mittens wrote: